Some three months after federal officials called for a manufacturing pause, Emergent BioSolutions has righted the ship at its beleaguered Bayview facility. Emergent won the FDA’s blessing to restart production of Johnson & Johnson’s COVID-19 vaccine at its Baltimore, Maryland, plant, the company said Thursday. The move follows “extensive” FDA reviews, plus “close coordination” with… Read More »
If you’ve already gotten your vaccine and moved swiftly into the phase of worrying about losing your vaccine card — you’re not alone. To keep it protected, instead of going through the hassle of laminating it, why not invest in one of these easily accessible storage methods? From a smart band that you can keep… Read More »
As The Mirror reported this week, Covid vaccination take-up has dramatically slowed across the UK this month as fewer young people take up the offer to get their first dose. Here we ask 28-year-old Hannah why she’s chosen not to get jabbed – and how she feels about being branded ‘selfish’ as a result. My… Read More »
Congress.gov: “H.R.1978 — Protecting Seniors Through Immunization Act of 2021,” “S.912 — Protecting Seniors Through Immunization Act of 2021.” EnergyCommerceHouse.gov: “L.J. Tan, MS, PhD, Chief Strategy Officer, Immunization Action Coalition, Testimony Before the House Energy and Commerce Committee Subcommittee on Health.” Avalere: “Medicare Part D Plans Continue to Require Cost Sharing for Vaccines.” Immunization Action… Read More »
The U.S. has been one of Moderna’s most lucrative COVID-19 vaccine customers as the biotech vies for at least $ 19 billion in pandemic shot sales by year’s end. Just how lucrative? As part of its latest supply deal announced last week, the U.S. will dish out $ 3.3 billion for 200 million shots from… Read More »